Lata Vadlamudi
Overview
Explore the profile of Lata Vadlamudi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
394
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tupil A, Rivlin W, McCombe P, Henderson R, Rodgers J, Vadlamudi L
Neurol Genet
. 2025 Jan;
10(6):e200205.
PMID: 39807213
Tay-Sachs disease is a neurodegenerative disorder characterized by progressive neurologic impairment due to pathogenic variants in the gene that codes for the alpha subunit of β-hexosaminidase. We report 2 cases...
2.
Green T, Bennett M, Immisch I, Freeman J, Klein K, Kerrigan J, et al.
Genet Med Open
. 2024 Dec;
1(1):100810.
PMID: 39669239
Purpose: Hypothalamic hamartoma (HH) can be syndromic (eg, Pallister-Hall syndrome [PHS], HH, and mesoaxial polydactyly) or nonsyndromic. Most PHS cases have germline variants in , but a minority remain unresolved....
3.
Vadlamudi L, Ashley D, Voinescu P
Front Glob Womens Health
. 2024 Jun;
5:1363470.
PMID: 38933454
Epilepsy, is a serious neurological condition, characterized by recurring, unprovoked seizures and affects over 50 million people worldwide. Epilepsy has an equal prevalence in males and females, and occurs throughout...
4.
Robertson A, Tran K, Bennett C, Sullivan C, Stark Z, Vadlamudi L, et al.
Sci Rep
. 2024 Apr;
14(1):7717.
PMID: 38565608
Despite the significant advances in understanding the genetic architecture of epilepsy, many patients do not receive a molecular diagnosis after genomic testing. Re-analysing existing genomic data has emerged as a...
5.
Perucca P, Bourikas D, Voinescu P, Vadlamudi L, Chellun D, Kumke T, et al.
Epilepsia
. 2024 Feb;
65(5):1275-1284.
PMID: 38411300
Objective: In pregnancy, it is important to balance the risks of uncontrolled epileptic seizures to the mother and fetus against the potential teratogenic effects of antiseizure medications. Data are limited...
6.
Gordon L, Elliott T, Bennett C, Hollway G, Waddell N, Vadlamudi L
Epilepsia
. 2022 Sep;
63(12):3111-3121.
PMID: 36082520
Objective: Existing gene panels were developed to understand the etiology of epilepsy, and further benefits will arise from an effective pharmacogenomics panel for personalizing therapy and achieving seizure control. Our...
7.
Vadlamudi L, Bennett C, Tom M, Abdulrasool G, Brion K, Lundie B, et al.
J Clin Med
. 2022 Jul;
11(14).
PMID: 35888005
Background: The genomic era has led to enormous progress in clinical care and a multi-disciplinary team (MDT) approach is imperative for integration of genomics into epilepsy patient care. Methods: The...
8.
Hunter Z, Leeson H, Shaker M, Wolvetang E, Vadlamudi L
Stem Cell Res
. 2022 Jan;
60:102673.
PMID: 35074713
In this paper, we describe the generation and validation of human induced pluripotent stem cell (hiPSC) lines from peripheral blood mononuclear cells (PBMCs) from 6 epilepsy patients using a non-integrative...
9.
Hunter Z, Leeson H, Shaker M, Wolvetang E, Vadlamudi L
Stem Cell Res
. 2021 Oct;
56:102564.
PMID: 34649201
Epilepsy is a common neurological disorder characterized by seizures. Unfortunately, 30-40% of all epilepsy patients are resistant to at least two or more anti-seizure medications. Attempts to treat these patients...
10.
Rodriguez-Acevedo A, Gordon L, Waddell N, Hollway G, Vadlamudi L
Pharmacogenomics
. 2021 Mar;
22(4):225-234.
PMID: 33666520
Evaluating genes involved in the pharmacodynamics and pharmacokinetics of epilepsy drugs is critical to better understand pharmacoresistant epilepsy. We reviewed the pharmacogenetics literature on six antiseizure medicines (carbamazepine, perampanel, lamotrigine,...